Initial dose: 510 mg, IV, over at least 15 minutes Second dose: 510 mg, IV, over at least 15 minutes, 3 to 8 days after the initial dose Comments: -The patient should be reclined or semi-reclined during administration. -Evaluate hematologic response at least one month after the second...
IV Iron and Phosphate FERAHEME vs Injectafer®(ferric carboxymaltose) FERAHEME vs Venofer®(iron sucrose) Patient-Reported Outcomes Specialty Specific FERAHEME Safety FERAHEME Dosing & Administration How to Order Billing & Coding Patient Support ...
FERAHEME comes in single-dose vials (510 mg elemental iron in 17 mL) Administer as an IV infusion over at least 15 minutes when the patient is in a reclined or semi-reclined position Closely observe patients for signs or symptoms of hypersensitivity reactions, including monitoring of blood ...
997 patients exposed to a 1.02 g course of ferumoxytol administered as two 510 mg intravenous (IV) doses: 992 subjects (99.5%) received at least 1 complete dose of ferumoxytol and 946 subjects (94.9%) received 2 complete doses. The mean cumulative IV Iron exposure was 993.80 ±119.085 mg...
81.1% FERAHEME VS 5.5% Placebo See results Improvements in FACIT-Fatigue score from baseline1 11.7points FERAHEME VS 6.8points Placebo See results Durability of response2 61% of patients did not require a second course of treatment over a 6-month period ...